Unlock the Glow Code
A Patent Pending blend of solution
VAMP™ products are patent-pending, topical sterile bio-revitalizing solution enriched with a powerful blend of Hyaluronic Acid, Vitamins, Amino acids, Minerals and medical-grade high purity Polydeoxyribonucleotides (PDRN) for skin rejuvenation and revitalization.
They help to improve skin tonicity, tighten pores and smooth wrinkles. Overall, restoring skin's glow by improving skin texture and hydration.
How Each
Ingredient
Works
Each component in the VAMP™ formulation plays a different role in skin rejuvenation. Here's how these high-performance ingredients work together to deliver visible results:
Vitamins:
Hydration, Improve elasticity, Skin revitalization
Amino acids:
Reduce appearance of aging, Improve skin tonicity
Minerals:
Skin barrier support, Overall skin health
PDRN:
Tighten skin, Improve elasticity
Hyaluronic Acid (HA):
Hydration
What Makes
VAMP™ Different
Polydeoxyribonucleotides
(PDRN)
Polydeoxyribonucleotides (PDRN) are fragments of low molecular weight DNA extracted from wild
salmon, purified to over 95% to ensure safety, stability, and biocompatibility1.
They are clinically proven to offer key benefits towards skin rejuvenation.
- Reduces the appearance of aging2
- Tightens and improves skin's elasticity2
Medical Grade Ingredients3
VAMP™ is manufactured using only high-purity medical grade PDRN, which meets strict standards for safety and clinical efficacy, and potentially lower risk of infection.
| Tests/Standard | Medical Grade PDRN |
Cosmetic Grade PDRN |
|---|---|---|
| Microbiological Quality Bacteria | ≤ 100 CFU/g | ≤ 500 CFU/g |
| Microbiological Quality Yeast & Mould | ≤ 10 CFU/g | ≤ 100 CFU/g |
| Bacterial Endotoxin | < 0.5 I.U./mg | No standard |
| Elemental Impurities | Range from < 0.2 ppm to < 1.5 ppm |
No standard |
Cocktail of nutrients
VAMP™ is a complete, pre-mixed formula — sterile, stable, and balanced — all in a single ready-to-use syringe.
- 11 Vitamins
- 23 Amino Acids
- 6 Minerals
- Medical-Grade PDRN
- Hyaluronic Acid
- Squadrito F et al., Frontiers in Pharmacology. 2017;8:224.
- Khan A et al., CJPRS. 2022;4:187.
- Data on file; HTL Biotechnology, 2023